Clinical Trials in Florida

Showing 9681-9700 of 10,975 trials

Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma

NCT00243035

This phase I/II trial is studying the side effects and best dose of tipifarnib when given together with bortezomib and to see how well they work in treating patients with relapsed multiple myeloma. Tipifarnib and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving tipifarnib together with bortezomib may kill more cancer cells.

Refractory Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma

National Cancer Institute (NCI)64 participantsStarted Aug 2005

Tampa, Florida, United States

COMPLETEDNA49 miles

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

NCT00004735

The purpose of this study is to determine the number of newly formed CD4 cells in children who have taken anti-HIV drugs. The study will also evaluate the effectiveness of the new CD4 cells in producing an immune response to hepatitis A and tetanus toxoid vaccination. Study hypothesis: 1) Immunologic reconstitution of individuals who have less than 15% CD4 cells may or may not be associated with functional activity. 2) The functional immunologic responses to recall and newly experienced antigens may be different. 3) The functional responses to antigens delivered in vaccine format may be a function of CD4 level, viral load, or both.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)81 participantsStarted Feb 2000

Birmingham, Alabama, United States • Alhambra, California, United States • Long Beach, California, United States +24 more locations

Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Find Trials by Condition in Florida

A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes

Erlotinib Study for Myelodysplastic Syndrome (MDS)

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

RESTART C0168Z05 Rheumatoid Arthritis Study

Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Nutrition Intervention in Treating Women With Breast Cancer

Treatment Interruption of Natalizumab

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

Intervention to Retain HIV-positive Patients in Medical Care

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma